Symbol
Aligos Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$5.05
Current price of the stock
$428K
Trading volume of the stock
$31.7M
Market capitalization of the company
Nano Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
1913.19%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.00
Total debt to total equity ratio
3.81
Current ratio
100.00%
Gross profit margin
-1586.37%
Operating profit margin
-1586.37%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1510.48%
Pretax profit margin
-1517.65%
Net profit margin
-38.44%
Measures profitability relative to shareholders' equity
-38.44%
ROE excluding intangible assets
-21.78%
Measures profitability relative to total assets
-38.30%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.68
Measures valuation relative to earnings
-
P/E based on future earnings estimates
5.28
Measures valuation relative to sales
0.34
Measures valuation relative to book value
-0.10
Measures valuation relative to operating cash flow
-0.10
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
